The hepatotoxic metabolite of acetaminophen directly activates the Keap1-Nrf2 cell defense system

Ian M Copple1, Christopher E Goldring, Rosalind E Jenkins

  • 1Department of Pharmacology and Therapeutics, School of Biomedical Sciences, The University of Liverpool, Liverpool, UK.

Hepatology (Baltimore, Md.)
|September 12, 2008
PubMed
Abstract

Insights

Acetaminophen metabolite NAPQI directly activates the Nrf2 pathway by modifying Keap1. Nrf2 activation also occurs via glutathione depletion, suggesting dual mechanisms protect against drug-induced liver injury.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Toxicology

Background:

  • Nuclear factor erythroid 2-related factor 2 (Nrf2) controls cytoprotective genes.
  • Acetaminophen activates Nrf2, suggesting a role in preventing drug-induced liver injury.
  • Nrf2 activation is linked to cysteine modification in Keap1, its repressor.

Purpose of the Study:

  • To investigate if acetaminophen's metabolite, NAPQI, activates Nrf2 by modifying Keap1.
  • To elucidate the mechanisms of Nrf2 activation by acetaminophen.

Main Methods:

  • NAPQI administration to mouse liver cells.
  • RNA interference targeting Nrf2.
  • Mass spectrometry to analyze Keap1 cysteine modification.
  • Cell-based models with probe molecules and glutathione depletion.

Main Results:

  • NAPQI directly activated the Nrf2 pathway in mouse liver cells.
  • NAPQI selectively modified cysteine residues in Keap1.
  • Glutathione depletion also activated Nrf2, independent of direct Keap1 modification.

Conclusions:

  • Nrf2 activation can occur through direct Keap1 cysteine modification by NAPQI.
  • Nrf2 can also be activated by significant glutathione depletion.
  • Both pathways may contribute to acetaminophen-induced Nrf2 activation.

Related Concept Videos

Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation01:22

Phase II Reactions: Glutathione Conjugation and Mercapturic Acid Formation

Glutathione, a tripeptide made up of glutamate, cysteine, and glycine, is a critical player in the detoxification of drugs and xenobiotics via a process known as glutathione conjugation or mercapturic acid formation. This phase II biotransformation reaction involves the covalent binding of glutathione to a drug or its metabolite, enhancing the compound's water solubility and enabling its excretion.
Several distinctive characteristics distinguish glutathione conjugation from other phase II...
Phase II Reactions: Acetylation Reactions01:24

Phase II Reactions: Acetylation Reactions

Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems01:19

Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems

Phase I biotransformation reactions are integral to drug metabolism, predominantly involving oxidative, reductive, and hydrolytic transformations. Chief among these are oxidative reactions, which enhance the hydrophilicity of xenobiotics and introduce polar functional groups to facilitate their elimination from the body.
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...